89 related articles for article (PubMed ID: 4447926)
1. Comparison of treatments for prostatic cancer using an exponential-type life model relating survival to concomitant information.
Bayard S; Greenberg R; Showalter D; Byar D
Cancer Chemother Rep; 1974; 58(6):845-59. PubMed ID: 4447926
[No Abstract] [Full Text] [Related]
2. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
Gleason DF; Mellinger GT
J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
[No Abstract] [Full Text] [Related]
3. An exponential model relating censored survival data and concomitant information for prostatic cancer patients.
Byar DP; Huse R; Bailar JC
J Natl Cancer Inst; 1974 Feb; 52(2):321-6. PubMed ID: 4856154
[No Abstract] [Full Text] [Related]
4. [Rate of survival in prostatic cancer with bone metastasis].
Kuntz D; Ryckewaert A
Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263
[No Abstract] [Full Text] [Related]
5. Endocrine treatment of cancer of the prostate.
Madsen PO; Pedersen JF; Knuth OE
Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
[No Abstract] [Full Text] [Related]
6. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
Bhanalaph T; Varkarakis MJ; Murphy GP
Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
[No Abstract] [Full Text] [Related]
7. Prostatic carcinoma.
Klein LA
N Engl J Med; 1979 Apr; 300(15):824-33. PubMed ID: 106277
[No Abstract] [Full Text] [Related]
8. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
Breitwieser P; Nöske HD
Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
[No Abstract] [Full Text] [Related]
9. Biologic and pathophysiologic prognosticating indices in prostatic cancer.
Madduri SD; Sporer A; Seebode JJ
Am Surg; 1978 May; 44(5):290-5. PubMed ID: 666117
[No Abstract] [Full Text] [Related]
10. [Prognosis and treatment of prostatic carcinoma].
Klug W
Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
[No Abstract] [Full Text] [Related]
11. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
Blackard CE; Byar DP; Jordan WP
Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
[No Abstract] [Full Text] [Related]
12. Prostatic carcinoma treated at categorical center: clinical and pathologic observations.
Schoonees R; Palma LD; Gaeta JF; Moore RH; Murphy GP
N Y State J Med; 1972 May; 72(9):1021-7. PubMed ID: 4502386
[No Abstract] [Full Text] [Related]
13. Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol.
Jönsson G
Scand J Urol Nephrol; 1971; 5(2):97-102. PubMed ID: 5093112
[No Abstract] [Full Text] [Related]
14. Cancer of the prostate.
N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
[No Abstract] [Full Text] [Related]
15. [Endocrine therapy of prostatic cancer].
Shimazaki J; Fuse H; Zama S
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of prostatic cancer.
Arvola I; Lilius HG; Uusi-Penttilä S
Ann Chir Gynaecol Fenn; 1972; 61(1):25-9. PubMed ID: 5021539
[No Abstract] [Full Text] [Related]
17. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
Blackard CE; Doe RP; Mellinger GT; Byar DP
Cancer; 1970 Aug; 26(2):249-56. PubMed ID: 4916019
[No Abstract] [Full Text] [Related]
18. Prostatic adenocarcinoma of ductal origin.
Dube VE; Farrow GM; Greene LF
Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
[No Abstract] [Full Text] [Related]
19. [Prostatic cancer: indications for hormone therapy].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
[No Abstract] [Full Text] [Related]
20. [Advanced prostatic cancer: therapeutic modalities].
Faul P; Altwein JE
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1975-80. PubMed ID: 6391887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
